Business Overview

RETURN ON INVESTMENT
AI-HEALTH

Key Feature: Hyper Growth

Return On Investment

EXIT

VALUE | RETURN

£150 m £125,000
£250 m £208,000
£400 m £333,000

£25,000 INVESTMENT

No Debt Capital for Cashflow

We have developed and built out the world's most advanced health/fitness ecosystem. New capital is to support revenue and growth, not R&D

Return on Investment (ROI) – offering exceptional individualised, gamified user intervention AI Health’s business model is meticulously designed to deliver superior ROI by leveraging its comprehensive suite of AI-driven health applications.

The £1,000,000 Capital Raise - will be strategically allocated towards marketing, promotional activities, and essential hires in finance, marketing, and social content creation, ensuring operational efficiency and maximising profit margins.

The Company’s Strategic Advantage - lies in its fully developed applications, which eliminate ongoing R&D expenses for the foreseeable future. This allows for the redirection of resources towards market expansion and user acquisition. Financial projections estimate an Annual Recurring Revenue (ARR) of £88,470,012 within the first year post-launch of all applications, with a cash-positive status anticipated within eight weeks of the initial app launch. This rapid revenue generation underscores the potential for substantial and swift returns on investment.

AI Health’s Zero-Debt - status and lean cost structure further enhance its ROI potential.

With current operational overheads maintained at a minimal £30k per month - a higher proportion of revenue can be converted into profit. This strategic focus on marketing and user acquisition, combined with disciplined financial management, positions AI Health for sustained profitability and attractive returns for investors.

Exits in Our Sector

= ARR x 14/22

THE VISION

Accessible apps for all, a technological intervention that can assess, educate and guide all within the global community.

Measurable decreased risk to CVD / MetS.

Reversing of metabolic dysfunctional conditions; IR, MetS, T2D, T3, Obesity

Hyper-Growth Strategy – AI Health’s hyper-growth strategy is underpinned by its fully developed, technologically advanced suite of AI-driven health applications. This strategic position enables the company to bypass the common challenges of continuous development, focusing instead on scaling its market presence.

The Market Penetration and Expansion: The successful pre-order numbers for the Walk Ailly app set a positive precedent for subsequent launches. The staggered release of additional applications every 4-6 weeks will maintain market momentum and user engagement, facilitating rapid user base expansion.

The Strategic Partnerships: Collaborations with publicists, sports clubs and industry / lifestyle influencers will enhance market credibility and broaden reach, driving user acquisition and retention. These partnerships are crucial for building a strong user community and fostering brand loyalty.

Comprehensive Marketing Campaigns: AI Health's marketing strategy includes high-volume ground content, paid advertising, and influencer partnerships. These campaigns are designed to highlight the unique benefits of its personalised, scientifically validated health interventions, increasing visibility and user engagement.

Operational Efficiency: With no further development costs, AI Health operates with a lean structure, directing investment primarily towards marketing and user acquisition. This operational efficiency facilitates rapid scalability, enabling quick market penetration and significant revenue growth.

Global Expansion: AI Health plans to expand globally, adapting its applications for local markets and forming strategic partnerships to support international market entry. This global strategy will leverage localised marketing efforts and partnerships to maximise market penetration.